Loading…
Respiratory Dysfunction Is Common in Patients with Achalasia and Improves After Pneumatic Dilation
Background Dysphagia, regurgitation, and chest pain are common achalasia, with a variable report of pulmonary symptoms possibly due to micro-aspiration. Pneumatic dilation (PD) may improve pulmonary function. Data on pulmonary dysfunction among achalasia patients are scanty, and the effect of PD is...
Saved in:
Published in: | Digestive diseases and sciences 2014-04, Vol.59 (4), p.744-752 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Dysphagia, regurgitation, and chest pain are common achalasia, with a variable report of pulmonary symptoms possibly due to micro-aspiration. Pneumatic dilation (PD) may improve pulmonary function. Data on pulmonary dysfunction among achalasia patients are scanty, and the effect of PD is unknown.
Aim
To evaluate pulmonary dysfunction in patients with achalasia based on clinical and radiologic evaluation and spirometry and to study the effect of PD at 1-month follow-up.
Methods
Patients with achalasia (diagnosed using high-resolution manometry and the Chicago classification) were evaluated prospectively by spirometry before (
n
= 38) and 1 month after PD (
n
= 31). All patients received a chest X-ray, and patients with respiratory abnormality before PD received high-resolution computed tomography of the thorax.
Results
Of the 38 patients, 17 and 21 had type I and II achalasia, respectively. The respiratory symptoms, such as pharyngeal symptoms [27/38 (71 %) vs. 8/31 (26 %);
P
= 0.0001], cough [23/38 (60.5 %) vs. 5/31 (16 %),
P
= 0.0001], and dyspnea [8/38 (21 %) vs. 0/31 (0 %),
P
= 0.006], improved after treatment with PD. Spirometry showed abnormalities in 17/38 (45 %) patients before and in 8/15 (53 %) after PD. Median FEV
1
, FVC, PEFR, and percentage of predicted MEF
25–75
, improved from 78 % (36–85), 74 % (48–100), 62 % (18–72), and 48 % (15–66) before to 83 % (58–94), 86 % (55–99), 69 % (38–81), and 59 % (33–78) after PD, respectively (
P
|
---|---|
ISSN: | 0163-2116 1573-2568 |
DOI: | 10.1007/s10620-013-2971-8 |